The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination developed by SQ Innovation, Inc., for treating edema caused by chronic heart ...

Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...

A new study from Karolinska Institutet suggests that some widely used heartburn medications may be linked to kidney problems ...

Some foods affect blood pressure medicines. These include grapefruit, grapefruit juice, aged cheese, foods high in sodium or ...

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...

Novo Nordisk (NVO) stock is in focus as the FDA OKs a label revison for the company's GLP-1 pill Rybelsus to cut ...

A new study out of Europe has called into question the effectiveness of beta blockers, one of the most frequently prescribed ...

A new pill called baxdrostat may offer hope for people whose blood pressure stays high even after taking standard medications ...

Researchers are calling for a new approach to drug development in cardiovascular disease (CVD), using artificial intelligence (AI), omics technologies, and systems biology to address treatment gaps in ...

It has been a roller coaster ride for Cytokinetics, Inc. CYTK so far in 2025. While the delay in FDA approval of its lead candidate aficamten for the treatment of patients with obstructive ...

The National Agency for Food and Drug Administration and Control has announced the withdrawal, suspension, or cancellation of 101 pharmaceutical products, effective immediately. The decision is ...